Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Progress in Lipid Research|September 11, 2025
Targeting fatty acid-binding protein 4: A therapeutic intersection of obesity and cancer via lipid metabolismKatarzyna Smolińska, Aleksandra Szopa, Piotr Dobrowolski, et al.
Plos One|May 11, 2010
A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responsesVille Härmä, Johannes Virtanen, Rami Mäkelä, et al.
Cancer Research|August 18, 2010
FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cellsSantosh Gupta, Kristiina Iljin, Henri Sara, et al.
Small Science|April 11, 2025
Surface Modification of Mesoporous Silica Nanoparticles as a Means to Introduce Inherent Cancer-Targeting Ability in a 3D Tumor MicroenvironmentNeeraj Prabhakar, Erica Långbacka, Ezgi Özliseli, et al.
Nature Communications|May 3, 2018
Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancerVirginia Murillo-Garzón, Irantzu Gorroño-Etxebarria, Malin Åkerfelt, et al.
Scientific Reports|August 22, 2023
Evaluation of the anticancer activity of RIN-1, a Notch signaling modulator, in head and neck squamous cell carcinomaArkadiusz Czerwonka, Joanna Kałafut, Shaoxia Wang, et al.
Scientific Reports|March 17, 2021
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancerNataliia Petruk, Sanni Tuominen, Malin Åkerfelt, et al.
European Journal of Cell Biology|April 12, 2005
Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinomaMariana Roesch Ely, Matthias Nees, Syrus Karsai, et al.
Scientific Reports|January 17, 2025
Loss of Sirtuin 7 impairs cell motility and proliferation and enhances S-phase cell arrest after 5-fluorouracil treatment in head and neck cancerMarta Halasa, Syeda Afshan, Anna Wawruszak, et al.
Cancer Research|November 3, 2006
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogrammingKristiina Iljin, Maija Wolf, Henrik Edgren, et al.
Pageof 6